Monday - January 26, 2026

Category Archives: Services

NK Cell Therapy Market 2034: 7MM Outlook, 30+ Active Developers, IND/NDA Momentum, and Next-Gen CAR-NK Innovations Driving Immunotherapy Advances | DelveInsight

NK Cell Therapy Market Major developers active in the NK cell therapy space include MiNK Therapeutics, Indapta Therapeutics, ImmunityBio, Inc., Allife Medical Science and Technology, Biohaven Pharmaceuticals, Acepodia, Bright Path Biotherapeutics, Amgen, Innate Pharma, Nektar Therapeutics, SMT bio Co., Ltd., … Continue reading →

Refractory Metastatic Melanoma Clinical Trial Pipeline Accelerates as 4+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Refractory Metastatic Melanoma Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Alopecia Areata Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Alopecia Areata Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Alopecia Areata pipeline landscape. It covers the Alopecia Areata pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Menkes Disease Market Report 2034: 7MM Analysis, USD 7.9 Million Market Size in 2023, 177 Diagnosed Cases, FDA Approvals & Clinical Pipeline | DelveInsight

Menkes Disease Market The report examines Menkes disease across the 7MM, highlighting epidemiology trends, 177 diagnosed prevalent cases, recent FDA approval of Zycubo, current treatment practices, emerging therapies, and key companies shaping the treatment landscape through 2034. The Menkes disease … Continue reading →

Acute Myeloid Leukemia Market Forecast to 2034: 7MM Opportunity, Strong CAGR, 43,500 Annual Cases, and Pipeline-Driven Growth | DelveInsight

Acute Myeloid Leukemia Market Robust R&D activity, breakthrough regulatory designations, and precision oncology approaches are driving meaningful change in AML care and commercial dynamics. The Acute Myeloid Leukemia (AML) market is expected to grow at a strong CAGR through 2034 … Continue reading →

NM-8074 (Ruxoprubart) Sales Forecast Signals Strong Long-Term Growth Potential Across Complement-Mediated Diseases Through 2034, DelveInsight

NM-8074 (Ruxoprubart) Sales Forecast NM-8074 (ruxoprubart) sales market analysis provides in-depth insights into NM-8074 annual sales, market size, and growth forecast across the 7MM through 2034. The report evaluates NM-8074 sales potential by indication, pricing dynamics, competitive landscape, and regulatory … Continue reading →